Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of WRAIR Dengue Vaccine Formulations
NCT00239577Phase 2Completed
- Sponsor
- GSK
- Start
- Apr 2006
- Primary completion
- Jun 2007
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of T-DEN vaccine in dengue fever (4 arms), sponsored by GSK. Primary endpoints: Number of Subjects With Any and Grade 3 Solicited Local Symptoms, Number of Subjects With Any, Grade 3 and Related Solicited General Symptoms and 1 more. Started Apr 2006; status: completed.
02
Drugs
T-DEN vaccine
03
Conditions
dengue fever
Beyond the preview
Go deeper on NCT00239577.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00239577.